Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone

BACKGROUND: Poor control of type 2 diabetes results in substantial long-term consequences. Studies of new diabetes treatments are rarely designed to assess mortality, complication rates and costs. We sought to estimate the long-term consequences of liraglutide and rosiglitazone both added to glimepi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Sean D, Alfonso-Cristancho, Rafael, Conner, Chris, Hammer, Mette, Blonde, Lawrence
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667489/
https://www.ncbi.nlm.nih.gov/pubmed/19245711
http://dx.doi.org/10.1186/1475-2840-8-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667489/
https://www.ncbi.nlm.nih.gov/pubmed/19245711
http://dx.doi.org/10.1186/1475-2840-8-12

Ejemplares similares